BioSpace News Archive

Ryvu Therapeutics, a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, announced that the Company will participate in the following upcoming investors’ conferences.

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announces that it will present preclinical research supporting its planned second clinical indication, bile duct cancer, also known as cholangiocarcinoma, at the Global Embolization Oncology Symposium.

Equifund ( https://equifund.com ), a private market investment platform that delivers vetted, early-stage investment opportunities to the public, announces it successfully oversubscribed a Reg-CF offering for Kleiner Device Labs.

Headlands Research, a leading international network of clinical trial sites, announced today a partnership with Pfizer Inc. to launch new research sites in areas with highly diverse populations, further advancing Headlands’ mission to meaningfully increase diverse clinical trial participation.

Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a company focused on the development of rare cancer therapeutics, today announced that it is changing its name to Cornerstone Pharmaceuticals, Inc.

The American Cancer Society’s impact venture capital fund, BrightEdge LLC, reported $9.7 million in realized and unrealized investment gains on $18.5 million in invested capital through year-end 2021.

Dxcover Limited, a clinical stage diagnostics company developing its spectroscopic biopsy technology for early detection of multiple cancers, today announced that it will be presenting new data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 3-7.

Medtronic plc, a global leader in healthcare technology, announced that it will report financial results for its fourth quarter and full fiscal year 2022 on Thursday, May 26, 2022.

BiondVax Pharmaceuticals Ltd. announced that it will present in-person at the H.C. Wainwright Global Investment Conference, on May 24, 2022 in Miami, Florida.

LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of its regulatory, quality, CMC and clinical team.